Spotlight on Research

New Grant Awards

FRI is pleased to announce that the following researchers at its East Coast Social Research Center have recently received grant funding from the National Institute on Drug Abuse (NIDA). We would like to congratulate them as they embark on their timely and significant projects.    

	Timothy Kinlock, Ph.D., FRI Principal Investigator, received a five-year grant from NIDA entitled “Buprenorphine for Prisoners. ”  This is a randomized clinical trial that will test the effectiveness of providing buprenorphine in prison prior to release as compared to after release for the treatment of opioid dependent men and women.  It will also compare two post-release settings for continued buprenorphine treatment, namely an Opioid Treatment Program v. a Community Health Center.  The Co-Investigators on this project are Michael Gordon, D.P.A., and Robert Schwartz, M.D.
	Robert Schwartz, M.D., FRI’s Medical Director, received a three-year grant from NIDA entitled “Entry into Comprehensive Methadone Treatment via Interim Maintenance. ”  This study builds on the work done by Drs. Schwartz and Jaffe in a recently completed study which demonstrated that interim methadone treatment (i.e., daily methadone with only crisis counseling) was superior to waiting list control in terms of assuring methadone treatment entry and reducing heroin use and criminal behavior.  The new study is a randomized trial that will compare interim treatment to comprehensive methadone treatment.  The Co-Investigators on this project are Jerome Jaffe, M.D., and Sharon Kelly, Ph.D.